About
Daniel Oliver is the CEO and co-founder of Rejuvenate Bio, a San Diego biotechnology company developing gene therapies for aging and age-related diseases. Rejuvenate Bio says the company launched from George Church's lab at Harvard Medical School and the Wyss Institute, and Oliver previously co-founded Voxel8. Public sources also identify him as a former Blavatnik Fellow at Harvard Business School with a background in commercializing science-driven startups.
Areas of interest
longevitybiotechgene therapyaginganimal healthdeep tech3D printingmedical devicesassistive mobility